Keisuke Kakisaka

1.4k total citations
84 papers, 893 citations indexed

About

Keisuke Kakisaka is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Keisuke Kakisaka has authored 84 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Epidemiology, 54 papers in Hepatology and 21 papers in Surgery. Recurrent topics in Keisuke Kakisaka's work include Liver Disease Diagnosis and Treatment (53 papers), Liver Disease and Transplantation (36 papers) and Drug-Induced Hepatotoxicity and Protection (11 papers). Keisuke Kakisaka is often cited by papers focused on Liver Disease Diagnosis and Treatment (53 papers), Liver Disease and Transplantation (36 papers) and Drug-Induced Hepatotoxicity and Protection (11 papers). Keisuke Kakisaka collaborates with scholars based in Japan, United States and Kazakhstan. Keisuke Kakisaka's co-authors include Yasuhiro Takikawa, Yuji Suzuki, Hidekatsu Kuroda, Gregory J. Gores, Nathan W. Werneburg, Sophie C. Cazanave, Maria Eugenia Guicciardi, Steven F. Bronk, Justin L. Mott and Christian D. Fingas and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Scientific Reports.

In The Last Decade

Keisuke Kakisaka

81 papers receiving 881 citations

Peers

Keisuke Kakisaka
Paul Manka Germany
Yeon Seok Seo South Korea
Yedidya Saiman United States
Mashiko Setshedi South Africa
Gab Jin Cheon South Korea
Paul Manka Germany
Keisuke Kakisaka
Citations per year, relative to Keisuke Kakisaka Keisuke Kakisaka (= 1×) peers Paul Manka

Countries citing papers authored by Keisuke Kakisaka

Since Specialization
Citations

This map shows the geographic impact of Keisuke Kakisaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keisuke Kakisaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keisuke Kakisaka more than expected).

Fields of papers citing papers by Keisuke Kakisaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keisuke Kakisaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keisuke Kakisaka. The network helps show where Keisuke Kakisaka may publish in the future.

Co-authorship network of co-authors of Keisuke Kakisaka

This figure shows the co-authorship network connecting the top 25 collaborators of Keisuke Kakisaka. A scholar is included among the top collaborators of Keisuke Kakisaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keisuke Kakisaka. Keisuke Kakisaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuroda, Hidekatsu, Tamami Abe, Keisuke Kakisaka, et al.. (2024). Early Clinical Outcomes of Durvalumab Plus Tremelimumab in Unresectable Hepatocellular Carcinoma: A Real-World Comparison with First-Line or Later-Line Treatment. Drugs - Real World Outcomes. 11(4). 701–710. 2 indexed citations
2.
Endo, Kei, Keisuke Kakisaka, Tamami Abe, et al.. (2024). Positive impact of obesity on the prognosis of liver cirrhosis. Journal of Gastroenterology and Hepatology. 39(8). 1663–1672. 2 indexed citations
3.
Kakisaka, Keisuke, et al.. (2024). Nutritional management for acute liver failure. Hepatology Research. 54(8). 736–744. 1 indexed citations
4.
Tanaka, Atsushi, Keiji Tsuji, Yasuyuki Komiyama, et al.. (2024). RECAM‐J 2023—Validation and development of the Japanese version of RECAM for the diagnosis of drug‐induced liver injury. Hepatology Research. 54(6). 503–512. 7 indexed citations
5.
Endo, Kei, et al.. (2023). Annual changes in grip strength and skeletal muscle mass in chronic liver disease: observational study. Scientific Reports. 13(1). 1648–1648. 3 indexed citations
6.
Kakisaka, Keisuke, Hidekatsu Kuroda, Tamami Abe, et al.. (2023). Coincidental items in the definition of metabolic dysfunction‐associated fatty liver are useful in identifying patients having significant fibrosis with fatty liver. Hepatology Research. 53(9). 857–865. 2 indexed citations
7.
Yoshida, Yuichi, Akiko Suzuki, Tamami Abe, et al.. (2023). Seroprevalence and incidence of hepatitis E virus infection in the general population of Iwate prefecture, Japan: A retrospective cohort study. Hepatology Research. 54(1). 24–31. 4 indexed citations
8.
Sasaki, Akira, et al.. (2023). Effects of laparoscopic sleeve gastrectomy on nonalcoholic fatty liver disease and TGF-β signaling pathway. Endocrine Journal. 71(2). 139–152. 1 indexed citations
9.
Kakisaka, Keisuke, et al.. (2022). Excess fructose enhances oleatic cytotoxicity via reactive oxygen species production and causes necroptosis in hepatocytes. The Journal of Nutritional Biochemistry. 107. 109052–109052. 7 indexed citations
10.
Takahashi, Naoto, Akira Sasaki, Akira Umemura, et al.. (2022). Identification of a Fatty Acid for Diagnosing Non-Alcoholic Steatohepatitis in Patients with Severe Obesity Undergoing Metabolic Surgery. Biomedicines. 10(11). 2920–2920. 3 indexed citations
11.
Sasaki, Akira, Akira Umemura, Kazuyuki Ishida, et al.. (2022). The Concept of Indeterminable NASH Inducted by Preoperative Diet and Metabolic Surgery: Analyses of Histopathological and Clinical Features. Biomedicines. 10(2). 453–453. 4 indexed citations
12.
Kakisaka, Keisuke, et al.. (2021). Serum alpha-fetoprotein increases prior to fibrosis resolution in a patient with acute liver failure. Clinical Journal of Gastroenterology. 14(5). 1470–1475. 1 indexed citations
13.
Suzuki, Yuji, Akiko Suzuki, Keisuke Kakisaka, & Yasuhiro Takikawa. (2021). Acute liver failure precipitated by acute Budd‐Chiari syndrome and complete portal vein thrombosis. SHILAP Revista de lepidopterología. 9(5). e04326–e04326. 3 indexed citations
14.
Kakisaka, Keisuke, Yuji Suzuki, Hiroaki Abe, et al.. (2020). Early identification using the referral system prolonged the time to onset for hepatic encephalopathy after diagnosing severe acute liver injury. Scientific Reports. 10(1). 17280–17280. 3 indexed citations
15.
Kuroda, Hidekatsu, Tamami Abe, Yudai Fujiwara, et al.. (2020). Contrast‐Enhanced Ultrasonography–Based Hepatic Perfusion for Early Prediction of Prognosis in Acute Liver Failure. Hepatology. 73(6). 2455–2467. 14 indexed citations
16.
Endo, Kei, et al.. (2020). Calf and arm circumference as simple markers for screening sarcopenia in patients with chronic liver disease. Hepatology Research. 51(2). 176–189. 26 indexed citations
17.
Takikawa, Yasuhiro, Keisuke Kakisaka, Yuji Suzuki, et al.. (2020). Multicenter study on the consciousness‐regaining effect of a newly developed artificial liver support system in acute liver failure: An on‐line continuous hemodiafiltration system. Hepatology Research. 51(2). 216–226. 8 indexed citations
18.
Suzuki, Yuji, Keisuke Kakisaka, Ting Wang, et al.. (2019). IL‐8 induces transdifferentiation of mature hepatocytes toward the cholangiocyte phenotype. FEBS Open Bio. 9(12). 2105–2116. 10 indexed citations
19.
Kakisaka, Keisuke, et al.. (2018). Caspase‐independent hepatocyte death: A result of the decrease of lysophosphatidylcholine acyltransferase 3 in non‐alcoholic steatohepatitis. Journal of Gastroenterology and Hepatology. 34(7). 1256–1262. 13 indexed citations
20.
Kakisaka, Keisuke, Yuji Suzuki, Yohei Okada, et al.. (2017). Predictive formula of coma onset and prothrombin time to distinguish patients who recover from acute liver injury. Journal of Gastroenterology and Hepatology. 33(1). 277–282. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026